Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Nucleic Acids Research|August 19, 2025
MoDorado: enhanced detection of tRNA modifications in nanopore sequencing by off-label use of modification callersFranziskus N M Rübsam, Wang Liu-Wei, Yu Sun, et al.Current Medical Research and Opinion|November 6, 2025
Differences in treatment decision-making for non-small cell lung cancer among patients and physicians, by race and ethnicityLisa Dwyer Orr, Pratyusha Vadagam, Julie Vanderpoel, et al.Phlebology|August 8, 2020
Imaging findings of pelvic venous insufficiency in patients with postural orthostatic tachycardia syndromeMartha-Gracia Knuttinen, Kenneth S Zurcher, Neal Khurana, et al.American Heart Journal|October 12, 2010
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)Christian T Ruff, Robert P Giugliano, Elliott M Antman, et al.Obesity Surgery|January 10, 2018
Does Sleeve Shape Make a Difference in Outcomes?Adel Alhaj Saleh, Michal R Janik, Rami R Mustafa, et al.Lancet (London, England)|March 15, 2015
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.European Heart Journal|December 5, 2013
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48Deepak K Gupta, Amil M Shah, Robert P Giugliano, et al.Thrombosis and Haemostasis|March 9, 2012
Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillationDaniel E Salazar, Jeanne Mendell, Helen Kastrissios, et al.Current Medicinal Chemistry|December 23, 2021
Nanoparticles Mediated Target-specific Drug Delivery in Prostate Cancer: An In-depth ReviewTarun Kumar Upadhyay, Mohammed Irfan Ali, Fahad Khan, et al.Proceedings of the National Academy of Sciences of the United States of America|June 17, 2025
The oncogene SLC35F2 is a high-specificity transporter for the micronutrients queuine and queuosineLyubomyr Burtnyak, Yifeng Yuan, Erwina Stojek, et al.Pageof 9